Skip to main content

Table 2 Characteristics of the included studies

From: Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review

Author and publication year Country Study design Name/ number of prison(s) Intervention year Laboratory diagnostic method Outcome reported
Abebe et al., 2011 [32] Ethiopia Cross-sectional study Jijiga, Dire Dawa, and Harar 2008 Direct smear microscopy and culture Active TB
Adane et al., 2016 [33] Ethiopia Cross-sectional study Axum, Mychew, Adwa, Adigrat, Shire, Humera, Alamata, Mekelle, and Wukro 2014 Acid fast bacilli microscopy and culture Active TB
Adane et al., 2019 [62] Ethiopia Cluster-randomized trial Mekelle, Shire, Adawa, Abi Addi, Humera, Adigrat, Maichew, Alamata, Wukro, Axum, Dessie, Woldia, Fenote Selam, Debre Markos, Debre Tabor, and Bahir Dar. 2017 Clinical re-evaluation based on physician’s judgment, Xpert MTB/RIF assay with new sample, Culture and drug susceptibility testing, and chest X-ray Active TB
Addis et al., 2015 [34] Ethiopia Cross-sectional study Gondar Prison 2008 Acid fast staining technique Active TB
Adesokan et al., 2014 [35] Nigeria Cross-sectional study Agodi prison 2013 Löwenstein-Jensen slopes with pyruvate and/or glycerol Active TB
Agajie et al., 2018 [36] Ethiopia Cross-sectional study Metekel, Assosa, and Inkamash 2018 Gene expert Active TB
Ali et al., 2015 [37] Ethiopia Cross-sectional study Ambo, Asebeteferi, Asella, Bonga, Dilla, Harar, Jimma, Mizan, Nekemte, Shashemene, Sodo, Wolkite, and Yabelo 2013 Smear microscopy and solid culture Active TB
Banda et al., 2009 [38] Malawi Cross-sectional study Zomba Central, Chichiri, Maula, Chitipa, Karonga, Mzuzu, Ntcheu, Mwanza, Mikuyu, Nkhota-kota, Mulanje, Nkhata-bay, Kasungu, Chikwawa, Mzimba, Mpsyupsyu, Mangochi, and Domasi 2005 Sputum smear microscopy Active TB
Biadglegne et al., 2014 [39] Ethiopia Cross-sectional study Debrebrihan, Dessie, Woldia, Gondar, Debiretab, Bahir Dar, Fenoteselam, and Debremarkos 2013 Acid fast bacilli microscopy Active TB
Chigbu et al., 2010 [60] Nigeria Cohort study Aba Federal Prison 2007 Sputum-smear microscopy and sputum culture and tuberculin skin testing Active TB and LTBI
Ekundayo et al., 2015 [41] Nigeria Cross-sectional study Aba Federal Prison 2015 Sputum smear microscopy Active TB
Diendere et al., 2011 [40] Burkina Faso Cross-sectional study Ouagadougou prison 2009 BAAR detection was performed by direct examination of sputum Active TB
Fuge et al., 2016 [42] Ethiopia Cross-sectional study Hadiya Zone prison 2013 Compound light microscopy Active TB
Gebrecherkos et al., 2016 [43] Ethiopia Cross-sectional study Debark, Dabat, Chilga, and Gondar towns of North Gondar zone 2015 Acid fast bacilli and GeneXpert MTB/RIF assay Active TB
Beza et al., 2017 [44] Ethiopia Cross-sectional study Motta, Bichena, and Debre Markos 2016 Gene Xpert MTB/RIF Active TB
Habeenzu et al., 2007 [45] Zambia Cross-sectional study Central Lusaka, Kamwala Remand Lusaka, Mwenbeshi Open Air, Mazabuka District, Monze Open Air Choma State, Kalamo District, Livingstone Central, Mukobeko Maximum Kabwe, Mukobeko Medium Kabwe, Mpima Kabwe, Kansenshi Ndola, and Kanfinsa Kitwe 2001 Cultured for Mycobacterium tuberculosis. Antimicrobial resistance testing was performed by the resistance ratio method Active TB
Harris et al., 2014 [61] Zambia Cohort study Lusaka Central Prison 2011 Lowenstein-Jensen medium, liquid Mycobacterial Growth Indicator Tube 960 System, BD Microbiology Systems, and culture. Species identification and drug susceptibility testing performed with Genotype MTBDRplus Active TB
Henostroza et al., 2013 [46] Zambia Cross-sectional study Lusaka Central Prison 2011 Digital X-ray/sputum smear microscopy, LED fluorescence, Lowenstein-Jensen Medium) culture. Active TB
Kalonji et al., 2016 [47] Democratic Republic of the Congo Cross-sectional study Mbuji-Mayi Central Prison 2015 Clinical examination and bacteriological tests Active TB
Karamagi et al., 2018 [48] Uganda Cross-sectional study 16 central and farm prisons (Names not specified) 2017 Combined quality improvement with facility-led active case finding (QI-ACF) Active TB
Kayomo et al., 2018 [49] Democratic Republic of the Congo Cross-sectional study Mbuji-Mayi Central Prison 2015 Xpert MTB/RIF assay Active TB
Kwabla et al., 2015 [50] Ghana Cross-sectional study Ho Prison 2014 Sputum smear microscopy Active TB
Maggard et al., 2015 [51] Zambia Cross-sectional study Lusaka Central Prison, Livingstone Central Prison, Kabwe Prison Complex, 2011 Fluorescence microscopy, cultures, X-rays and physical examinations. Active TB
Merid et al., 2018 [52] Ethiopia Cross-sectional study Hawassa prison 2016 Acid-fast bacilli, smear microscopy and molecular diagnostic testing (Xpert® MTB/RIF) Active TB
Noeske et al., 2006 [53] Cameroon Cross-sectional study New Bell Central Prison of Douala 2004 Smear microscopy and/or culture Active TB
Owokuhaisa et al., 2014 [54] Uganda Cross-sectional study Mbarara Central prison located in Kiswahili cell Mbarara 2012 Ziehl-Neelsen technique Active TB
Seri et al., 2017 [55] Coˆte d’Ivoire Cross-sectional study three buildings of MACA: the men’s longterm detention building, the women’s detention building, and the infirmary inpatients ward 2015 Systematic direct smear microscopy, culture and chest X-ray) Active TB
Telisinghe et al., 2014 [56] South Africa Cross-sectional study Male’s prison block housing sentenced prisoners 2010 Chest radiograph and two spot sputum specimens for microscopy and culture. Active TB
Winsa et al., 2015 [57] Ethiopia Cross-sectional study Bedele woreda prison 2012 Ziehl-Neelsen staining technique Active TB
Zerdo et al., 2014 [58] Ethiopia Cross-sectional study The three prisons of Gamo Goffa Zone 2012 Sputum smear microscopy and culture on Lowenstein-Jensen media Active TB
Zishiri et al., 2015 [59] South Africa Cross-sectional study 4 facilities (2 large and 2 smaller) 2013 GeneXpert MTB/Rif) Active TB